ArticleClinical and translational science2022

Imeglimin population pharmacokinetics and dose adjustment predictions for renal impairment in Japanese and Western patients with type 2 diabetes.

Yoshiko Tomita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.